the aid library

LIST OPTIONS

Filter

9977

Mapping HIV prevalence in Africa for a better understanding of epidemics: example from Burkina Faso using 2003 Demographic and Health Survey data

Larmarnage J., Vallo R., Yaro S. et. al. (2010) C2

Since 2001, several Demographic and Health Surveys (DHS) include HIV testing. For many countries, in particular in sub-Saharan Africa, DHS are the only national source of data in general population. Several DHS collect latitude and longitude of surveyed clusters but the sampling method is not ap... more

Download (227)

View PDF (240)

Mantenimiento de la vigilancia de la gripe y seguimiento del SARS-CoV-2: adaptación del Sistema Mundial de Vigilancia y Respuesta a la Gripe (‎SMVRG)‎ y de los sistemas centinela durante la pandemia

Organización Mundial de la Salud OMS (2021) C_WHO

orientaciones provisionales, 8 de noviembre de 2020 This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e... more

Download (186)

View PDF (218)

Practical manual on tuberculosis laboratory strengthening, 2022 update

World Health Organisation (WHO) (2023) C_WHO

The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la... more

Download (452)

View PDF (761)

Advancing the right to health: the vital role of law
recommended

World Health Organization (WHO) (2017) C_WHO

This report aims to raise awareness about the role that the reform of public health laws can play in advancing the right to health and in creating the conditions for people to live healthy lives. By encouraging a better understanding of how public health law can be used to improve the health of the ... more

Download (276)

View PDF (373)

Alzheimer's disease facts and figures

J. Gaugler, Ph.D.; B. James, Ph.D.; T. Johnson, Ph.D., et al. Alzheimer's Association (2018) C2

Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis 2018 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’s disease, the most common cause of dementia. Background and context for interpretating the data are con... more

Download (539)

View PDF (854)

WHO recommendations on home-based records for maternal, newborn and child health

World Health Organization WHO (2018) C_WHO

The primary audience for the guideline is policy makers and health programme managers of MNCH and immunization programmes in ministries of health where decisions are made and policies created on the use and implementation of homebased records. The guideline is also aimed at health providers who use... more

Download (1731)

View PDF (5314)

Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings
recommended

World Health Organization WHO (2009) C2

These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to: • assess prevailing situations and plan for required improvements; • develop and reach essential safety standards as a f... more

Download (283)

View PDF (300)

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended

World Health Organization WHO (2022) C_WHO

This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19. In this edition, new information includes updated mask re... more

Download (592)

View PDF (1783)

Global Action Plan on Antimicrobial Resistance
recommended

World Health Organization WHO (2015) C_WHO

The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.

Download (129)

View PDF (169)

Infection prevention and control health-care facility response for COVID-19
recommended

World Health Organization WHO (2020) C_WHO

A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim Guidance 20 October 2020. This self-assessment tool is designed for acute health-care facilities (i.e. tertiary and secondary) but can be modified for the use in long-term care facilities... more

Download (369)

View PDF (649)

WHO Report on Surveillance of Antibiotic Consumption

World Health Organization WHO (2018) C_WHO

2016-2018 Early implementation, This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (... more

Download (966)

View PDF (1962)

A Review of Needs Assessment Tools, Response Analysis Frameworks, and Targeting Guidance for Urban Humanitarian Response

Lili Mohiddin, Gabrielle Smith International Institute for Environment and Development, Norwegian Refugee Council, International Rescue Committee, World Vision (2016) C1

The magnitude of urban disasters, high population densities, and a complex social, political and institutional environment has challenged the manner in which humanitarian agencies are used to working. Humanitarian agencies are now grappling with how to change their approaches to this reality. This d... more

Download (1973)

View PDF (3544)

Guidelines for the Management of Snake-bites. 2nd edition
recommended

Word Health Organization Regional Office of South-East Asia Word Health Organization Regional Office of South-East Asia (2016) C_WHO

Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortal... more

Download (1092)

View PDF (2206)

Community dialogues for healthy children: encouraging communities to talk

Malaria Consortium (2014)

Integrated community case management (ICCM) – an approach where community-based health workers are trained to identify, treat and refer children under-five with pneumonia, diarrhoea and malaria – is increasingly being used across sub-Saharan Africa to supplement the gaps in basic healthcare prov... more

Download (1291)

View PDF (2098)

WHO Pharmaceutical Situation Assessment – Level II – Health Facilities Services Ghana

Daniel Kojo Arhinful Ministry of Health, Ghana (2009) C1

This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r... more

Download (614)

View PDF (703)

A case study of the Essential Health Benefit in Tanzania mainland

Todd G.; Nswilla A.; Kisanga O.; Mamdani M. Regional Network for Equity in Health in east and southern Africa (EQUINET) (2017) C1

Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 109
This report describes the evolution of mainland Tanzania’s EHB; the motivations for developing the EHBs, the methods used to develop, define and cost them; how it is being disseminated, communicat... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (247)

View PDF (277)

WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended

World Health Organization WHO (2020) C_WHO

The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ... more

Download (204)

View PDF (238)

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

Download (197)

View PDF (221)

Interim Guidance on Public Health and Social Measures for COVID-19 Preparedness and Response Operations in Low Capacity and Humanitarian Settings

Inter-Agency Standing Committee IASC (2020) C1

This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co... more

Advancing the right to health: the vital role of law recommended

Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline recommended

Global Action Plan on Antimicrobial Resistance recommended

Infection prevention and control health-care facility response for COVID-19 recommended

Guidelines for the Management of Snake-bites. 2nd edition recommended

WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities recommended